High blood pressure in older subjects with cognitive impairment

Enrico Mossello1, David Simoni

  • 1University of Florence. enrico.mossello@unifi.it.

Insights

High blood pressure in older adults is complex, with midlife hypertension a risk for dementia. Lowering blood pressure may not significantly reduce dementia risk in the elderly, and aggressive treatment could be harmful.

Area of Science:

  • Gerontology
  • Neurology
  • Cardiovascular Medicine

Background:

  • High blood pressure (hypertension) and cognitive impairment frequently co-occur in older individuals.
  • Midlife hypertension is a recognized risk factor for cognitive decline and dementia.
  • The relationship between blood pressure and cognitive status in old age is complex and less understood.

Purpose of the Study:

  • To explore the intricate association between blood pressure and cognitive impairment in the elderly.
  • To evaluate the efficacy of blood pressure lowering interventions on dementia risk in older populations.
  • To clarify the prognostic significance of blood pressure in cognitively impaired older adults.

Main Methods:

  • Review of longitudinal studies on midlife hypertension and cognitive decline.
  • Analysis of clinical trial data on antihypertensive treatments and dementia risk in older subjects.
  • Examination of the impact of neurodegeneration on blood pressure in dementia onset.
  • Assessment of ambulatory blood pressure monitoring versus clinical readings for predicting outcomes.

Main Results:

  • The link between hypertension and cognitive impairment is less clear in old age compared to midlife.
  • Blood pressure-lowering effects show only borderline significance in reducing dementia risk in older trial participants.
  • Dementia onset may be associated with a secondary decrease in blood pressure due to neurodegeneration.
  • Aggressive blood pressure reduction might be detrimental for cognitively impaired older patients.

Conclusions:

  • Older individuals with cognitive impairment require careful antihypertensive management, guided by cognitive and motor screening.
  • Ambulatory blood pressure monitoring offers better predictive value for outcomes in cognitively impaired older adults than standard clinical measurements.
  • Further research is needed to establish optimal blood pressure targets for elderly individuals with cognitive impairment.

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.1K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
344
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
708
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
309